Evidence map›Paper›PMID 42205596›Full record

ArticleOpen forum infectious diseases2026

High-Altitude

Yalemwork Ewnetu, Tolulope Adeyemi Kayode, Colins O Oduma, Temitope M Adeyemi-Kayode, Aragaw Zemene, Wossenseged Lemma, Nega Berhane, Cristian Koepfli

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yalemwork EwnetuDepartment of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia.ORCID https://orcid.org/0009-0007-2195-5032
Tolulope Adeyemi KayodeDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Colins O OdumaDepartment of Biochemistry and Molecular Biology, Egerton University, Nakuru, Kenya.
Temitope M Adeyemi-KayodeDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Aragaw ZemeneDepartment of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia.
Wossenseged LemmaDepartment of Medical Parasitology, School of Biomedical and Laboratory Sciences, Collage of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Nega BerhaneDepartment of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia.
Cristian KoepfliDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.ORCID https://orcid.org/0000-0002-9354-0414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Ethiopian highlands >2000 m above sea level are classified as experiencing very low malaria transmission, but clinical case numbers have increased in recent years. Transmission intensity, and how many infections are imported from the lowlands, are not known. Methods: Surveys on subclinical prevalence were conducted in 8 sites across an altitude range of <1900 to 2900 m. Samples were screened by quantitative polymerase chain reaction (qPCR) and microscopy or rapid diagnostic testing (RDT). Data on recent travel were collected from subclinical and clinical individuals. Result: Among 1241 subclinical individuals, Conclusions: High prevalence at altitudes up to 2800 m, and a minority of individuals reporting recent travel, might indicate sustained local transmission in the Ethiopian highlands, though undocumented travel and

Indexed as

highland malariahrp2 deletionimported infectionqPCRsubclinical malaria

Identifiers

PMID42205596
PMCPMC13202210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.